Document Top

Bevacizumab plus IFN in mRCC

Latest clinical trial data on the efficacy of first-line Avastin plus IFN in mRCC (Dr Camillo Porta)

 

Hide Thumbnail Menu

Download

Download: Camillo Porta Webcast Slides

Latest Webcast

  • Recent results in advanced ovarian cancer

    Recent results in advanced ovarian cancer

    Incorporation of bevacizumab in the primary treatment of ovarian cancer (Prof Robert Burger)

    View

  • Avastin in ovarian cancer

    Avastin in ovarian cancer

    Avastin front-line in women with advanced ovarian cancer (Prof Antonio González Martín)

    View

  • Challenges in the treatment of mCRC

    Challenges in the treatment of mCRC

    Discussion of challenges in the treatment of mCRC (Prof Dirk Arnold)

    View

  • Maximising survival in NSCLC

    Maximising survival in NSCLC

    Anti-angiogenic therapy in NSCLC: real-life perspectives (Prof Jürgen Wolf)

    View

Back to Educational webcast Back to top

x

You are now leaving the www.avastin.net website. Links to all external sites are provided as a resource to our visitors. Hoffmann-La Roche Inc. ("Roche") accepts no responsibility for the content of these sites. Roche does not control these sites, and the opinions, claims, or comments expressed on these sites should not be attributed to Roche, except where indicated. We recommend that you consult with your physician or other healthcare provider to obtain more information about any Roche prescription medication.

OK Cancel